Why R&D labs in Hong Kong are scarce | Asian Business Review

Why R&D labs in Hong Kong are scarce

The demand for medical office buildings in Hong Kong is high, but hard to get.

The demand from the healthcare sub-sector for medical office buildings in Hong Kong is high, according to a CBRE report.

The typical size requirement for these spaces are relatively small at 2,000 square feet and below. Large tenants such as hospital clinics can occupy multiple floors.

However, acquiring space in Hong Kong is challenging.

For R&D labs, investors have to deal with government ownership of the Hong Kong Science Park, where space is not available for sale. The Science Park hosts advanced R&D facilities, and can accommodate approximately 150 biomedical companies.

There are opportunities in converting existing industrial buildings, however there are strict requirements that need to be followed, including floor loading, and power and water supply. Thus conversions can only be done for laboratory testing use, and not for high-end R&D.

Over the recent years, medical companies have chosen to convert industrial buildings or acquire land for purpose-built medical facilities.

Follow the link for more news on

Join Asian Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Bifacial solar market projected to reach $31.1b by 2031
Dual-sided solar panels can generate up to 30% more energy than traditional modules.
Human oversight key as AI advances: HSBC
AI tools should be deployed with strong oversight.
Global M&A rebounds sharply as 2025 deal value climbs to US$4.8t
Average EV/EBITDA multiples rose to 11.6 times, up one turn from 2024 but still below 2021 peaks. 

Exclusives

Human oversight key as AI advances: HSBC
AI tools should be deployed with strong oversight.
PLN expands gas, LNG network to support rising renewables
Gas is the stabilising force that lets the grid absorb more variable output.
Danantara sets tighter 2026 investment plan
Indonesia’s sovereign wealth fund will back only projects with clear commercial value.